Ausgabe 1/1998
Inhalt (13 Artikel)
Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex
Yoshihiro Masuda, Hiroyuki Kobayashi, James F. Holland, Takao Ohnuma
Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women
Tomoko Ohtsu, Hirofumi Fujii, Hisashi Wakita, Tadahiko Igarashi, Kuniaki Itoh, Shigeru Imoto, Masahiro Kohagura, Yasutsuna Sasaki
Toxicity of cytostatic drugs to normal bone marrow cells in vitro
Britt Sundman-Engberg, Ulf Tidefelt, Christer Paul
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo
Beverly A. Teicher, Julia S. Wong, Hideya Takeuchi, Laura M. Gravelin, Gulshan Ara, David Buxton
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Yoshinori Naoe, Masamichi Inami, Ssanae Matsumoto, Fusako Nishigaki, Susumu Tsujimoto, Ikuo Kawamura, Kikuo Miyayasu, Toshitaka Manda, Kyoichi Shimomura
Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients
Hildegunn Berntsen, Per Eystein Lønning, Dagfinn Ekse, Bjørn Netteland, Dag Clement Johannessen, Rolf Berge, Asbjørn Svardal
Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine
Annemieke Kuin, Marjanka Aalders, Martin A. van der Valk, Armin Frey, Harald H. H. W. Schmidt, Lou A. Smets
Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells
Bertrand Jacques Jean-Claude, Amir Mustafa, Z. Damian, Josie De Marte, Daniela Eliza Vasilescu, Rose Yen, Thak Hak Chan, Brian Leyland-Jones
Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer
Kunihiko Kobayashi, Ayako Shinbara, Mitsuhiro Kamimura, Yuichiro Takeda, Koichiro Kudo, Junzaburo Kabe, Suguru Hibino, Mitsunori Hino, Masahiko Shibuya, Shouji Kudoh
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients
P. Beale, I. Judson, J. Hanwell, C. Berry, W. Aherne, T. Hickish, P. Martin, M. Walker
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model
Henk-Jan Guchelaar, Istvan Vermes, Richard P. Koopmans, Chris P. M. Reutelingsperger, Clemens Haanen
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group
Franco M. Muggia, John A. Blessing, Howard D. Homesley, Joel Sorosky
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071)
Sridhar Mani, Lalitha Iyer, Linda Janisch, Xiaolin Wang, Gini F. Fleming, Richard L. Schilsky, Mark J. Ratain